Category Archives: Congressional Hearing

MYLAN’S EPIPEN JOINS CONGRESS’ PUBLIC EYE OF RADICAL PRICE INCREASES

Following last week’s congressional hearing of Mylan’s Epipen with the house committee on oversight and government reform, CEO, Heather Bresch was ridiculed by the public for alleging false profit margins and tax rates. Heather and her team said that after … Continue reading

Posted in biotech, Congress, Congressional Hearing, Corporate News, Drugs, EpiPen, Healthcare, Heather Bresch, Insurance, Mylan, Price, tax, Uncategorized | Leave a comment